Metastatic neuroblastoma in infancy: What does the pattern of metastases contribute to prognosis?

Medical and Pediatric Oncology

Volumn 35, Issue 6, 2000, Pages 683-687

  Hero, Barbara ^a   Simon, Thorsten ^a   Horz, Stefanie ^a   Berthold, Frank ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Infancy; Metastases; Neuroblastoma; Stage classification

Indexed keywords

BONE MARROW METASTASIS; BONE METASTASIS; BRAIN METASTASIS; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; INFANCY; INFANT; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SKIN METASTASIS;

FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0033646921     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001201)35:6<683::AID-MPO43>3.0.CO;2-F     Document Type: Conference Paper

References (17)

1. A study of congenital sarcoma of the liver and suprarenal
2. On suprarenal sarcoma in children with metastases in the skull
3. A proposed staging system for children with neuroblastoma
4. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma
5. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment
6. Nonparametric estimation from incomplete observations
7. Regression models and life tables
8. Testicular and paratesticular involvement by metastatic neuroblastoma
9. Biological factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study
10. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
11. Clinical relevance of CD44 cell surface expression and N-Myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
12. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis
13. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
14. Risk factors in neuroblastoma of infants
15. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life
16. The current contribution of molecular factors to risk estimation in neuroblastoma patients